Boundless Bio, Inc.

BOLD · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$27$24$11$34
Short-Term Investments$126$97$56$39
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$2$3$1$2
Total Curr. Assets$154$124$68$75
Property Plant & Equip (Net)$51$5$8$3
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$1$0$35
Tax Assets$0$0$0$0
Other NC Assets$1$1$1$1
Total NC Assets$52$6$9$39
Other Assets$0$0$0$0
Total Assets$206$130$77$114
Liabilities
Payables$1$2$1$1
Short-Term Debt$0$2$2$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$7$5$4$2
Total Curr. Liab.$8$9$8$4
LT Debt$48$0$3$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$248$148$148
Total NC Liab.$48$248$151$148
Other Liabilities$0$0$0$0
Cap. Leases$48$2$5$0
Total Liabilities$56$257$159$152
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$201-$136-$87-$41
AOCI$0$0-$0-$0
Other Equity$352$9$5$3
Total Equity$151-$127-$82-$38
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$206$130$77$114
Net Debt$21-$22-$6-$34